The New Oral Anticoagulants

dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorKhatib, Amin
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentDrimba, László
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.opponentdeptKenézy Kórház, Aneszteziológiai tanszékhu_HU
dc.date.accessioned2014-06-22T17:51:42Z
dc.date.available2014-06-22T17:51:42Z
dc.date.created2014-03-12
dc.date.issued2014-06-22T17:51:42Z
dc.description.abstractThe new oral anticoagulants were recently developed, which are very specific in their action. They are easy to administer, do not require routine monitoring, and have very few drug interactions. Favorably, they appear to be the ideal anticoagulants and thus most likely will eventually replace the older ones. This is proven as they have already received approval for several indications to prevent and treat thrombosis. The aim of the thesis is to discuss the properties of the new oral anticoagulants, review the clinical trials evaluating their efficacy and safety profiles, and highlight their advantages over the standard anticoagulants.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeMSc/MAhu_HU
dc.format.extent36hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/194734
dc.language.isoenhu_HU
dc.rights.accessno_restrictionhu_HU
dc.subjectnew oral anticoagulantshu_HU
dc.subjectdabigatranhu_HU
dc.subjectrivaroxabanhu_HU
dc.subjectapixabanhu_HU
dc.subject.dspaceDEENK Témalista::Orvostudomány::Farmakológiahu_HU
dc.subject.dspaceDEENK Témalista::Orvostudomány::Belgyógyászathu_HU
dc.titleThe New Oral Anticoagulantshu_HU
dc.title.subtitleRedefining the future of anticoagulation therapyhu_HU
Fájlok